Literature DB >> 7453086

Interaction of circulating immune complexes with granulocyte function in patients with rheumatoid arthritis.

B Bültmann, R Geitner, H Seibold, G Kratsch, O Haferkamp.   

Abstract

The sera and peripheral blood granulocytes of 10 patients with rheumatoid arthritis and of 10 healthy controls were investigated for the presence of soluble immune complexes and for cellular dysfunction. Using the Rajicell-radioimmunoassay, immune complexes were detected in 7 out of 10 rheumatoid sera. In one patient the presence of immune complexes was demonstrated by immunofluorescence. In all rheumatoid patients with circulating immune complexes decreased chemotactic reactivity and diminished bactericidal capacity of the neutrophils were observed. Incubation of rheumatoid granulocytes with pooled AB-serum or pretreatment of neutrophils of healthy controls with immune complexes containing rheumatoid sera resulted in a reduced number of comparable cellular dysfunctions including increased release of lysosomal enzymes, strongly correlated with the presence of intracellular phagocytosed immune complexes. Phagocytosis and increase of oxidative cell metabolism during phagocytosis were not influenced by circulating immune complexes. Based on our in vitro findings we suggest that the described immune complex-dependent granulocyte dysfunctions are possible responsible for the high risk of local or systemic bacterial diseases in patients with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7453086     DOI: 10.1007/bf01478460

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

1.  A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE.

Authors:  D J PROCKOP; W D DAVIDSON
Journal:  N Engl J Med       Date:  1964-02-06       Impact factor: 91.245

2.  INACTIVATION OF ESTROGEN BY RAT UTERINE PREPARATIONS.

Authors:  S J KLEBANOFF
Journal:  Endocrinology       Date:  1965-02       Impact factor: 4.736

3.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

Review 4.  [Spontaneous septic arthritides during rheumatoid arthritis].

Authors:  J L Kuntz; D Mansilla; J L Pasquali; L Asch
Journal:  Sem Hop       Date:  1977-01-23

5.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

6.  [On the mechanism of lysosomal enzyme release from neutrophilic granulocytes (author's transl)].

Authors:  C Holubarsch; J Galle; O Haferkamp
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1979-05-04

7.  Release of lysosomal enzymes from human polymorphonuclear leukocytes by soluble intermediate immune complexes.

Authors:  A D Morrison; W Pruzanski; N S Ranadive
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

8.  Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.

Authors:  H S Luthra; F C McDuffie; G G Hunder; E A Samayoa
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

9.  Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.

Authors:  A G Mowat; J Baum
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

10.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  10 in total

1.  Neutrophil enzyme activities in carrageenan-induced inflammation in rats.

Authors:  I Sopata; E Wojtecka-Lukasik; J Wize; S Maśliński
Journal:  Agents Actions       Date:  1989-08

2.  Fc receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E de Vries; P C Leyh; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

3.  Selective inhibition of human neutrophil chemotaxis by ECHO-virus, type 9.

Authors:  B Bültmann; H J Eggers; O Haferkamp
Journal:  Klin Wochenschr       Date:  1981-06-01

4.  Critical analysis of granulocyte function in 154 patients wtih different diseases.

Authors:  B Bültmann; A Wildfeuer; U Schindlbeck; E Kleihauer; H Heimpel; H J Wigger; O Haferkamp
Journal:  Klin Wochenschr       Date:  1982-10-15

5.  Lysostaphin-based assay of human granulocyte functions: a reevaluation.

Authors:  D Urbanitz; R Schneider; M Meier; D Kamanabroo; W Fegeler; J van de Loo
Journal:  Klin Wochenschr       Date:  1986-10-15

6.  Scanning electron microscopy of rheumatoid arthritis peripheral blood polymorphonuclear leucocytes.

Authors:  D A McCarthy; C M Holburn; B K Pell; S R Moore; A P Kirk; J D Perry
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

7.  Disseminated mycobacterial histiocytosis due to M. Fortuitum associated with helper T-lymphocyte immune deficiency.

Authors:  B D Bültmann; H D Flad; E Kaiserling; H K Müller-Hermelink; G Kratzsch; J Galle; W Schachenmayr; H Heimpel; H J Wigger; O Haferkamp
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

8.  A three-year prospective study of systemic manifestation in rheumatoid arthritis.

Authors:  H Mielke; W Daniel; H Deicher; W Drommer; M Fischer; R Fritsch; H Müller-Vahl; G W Sybrecht
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

9.  Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases.

Authors:  I Sopata; J Wize; A Filipowicz-Sosnowska; E Stanisławska-Biernat; B Brzezińska; S Maśliński
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

10.  Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.

Authors:  L R Coulthard; J Geiler; R J Mathews; L D Church; L J Dickie; D L Cooper; C Wong; S Savic; D Bryer; M H Buch; P Emery; A W Morgan; M F McDermott
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.